Scholars Central

OtherPublished 13 Jul 2016

Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology

Authors: Hann-Chorng Kuo

Clinical Investigation

Volume 2 · Issue 11 · Pages 1085–110

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Interstitial cystitis/bladder pain syndrome is characterized by bladder pain associated with urgency, frequency, nocturia, dysuria and sterile urine. Recent studies revealed that these bladder dysfunctions could originate from chronic inflammation or urothelial insult and proceed to a cascade of tissue reactions, which finally ascends to the CNS. The principles for treatment of interstitial cystitis/bladder pain syndrome are based on controlling the dysfunctional epithelium by continual replenishment of the glycosaminoglycan layer, inhibiting neurological hyperactivity by administration of amitriptyline or imipramine, suppression of allergies with antihistamines, and pain control with nonsteroidal anti-inflammatory drugs, COX-2 inhibitors or tranquilizers. Intravesical treatment with heparin, hyaluronic acid, chondroitin sulfate, Bacillus Calmette–Guérin, dimethylsulfoxide, resiniferatoxin, or botulinum toxin A has shown early effectiveness in some patients. Surgical treatment should be reserved for those who have no response to medical therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Investigation.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Investigation
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Hann-Chorng Kuo”